IDiyas

For the Inventor, By the Inventor

Paris, France

Gerard Defosse

USPTO Granted Patents = 9

Average Co-Inventor Count = 3.7

ph-index = 5

Forward Citations = 118(Granted Patents)


Company Filing History:

goldMedal9 out of 252 
 
Synthelabo
 patents

Years Active: 1984-1995

Loading Chart...
9 patents (USPTO):Explore Patents
1. 5418241 - Piperidine derivatives, their preparation and their application in (1995-05-23),
2. 5280030 - Piperidine derivatives, their preparation and their therapeutic (1994-01-18),
3. 5010079 - Indolone derivatives, their preparation and their application in therapy (1991-04-23),
4. 5001132 - Phenyloxypropanolamine derivatives and their application in therapeutics (1991-03-19),
5. 4963680 - Piperazine derivatives and their preparation process (1990-10-16),
6. 4912219 - 2-[4-pyrimidin-2-yl amino)piperidin-1-yl]benzimidazole compound (1990-03-27),
7. 4857536 - Antihistaminic benzimidazole derivatives (1989-08-15),
8. 4820710 - Benzimidazole derivatives and pharmaceutical compositions containing them (1989-04-11),
9. 4481207 - 1-Phenethyl-alpha-phenyl-piperidine-3-propanenitriles and their (1984-11-06),

Title: Gerard Defosse: Innovating in the Field of Piperidine Derivatives

Introduction

Gerard Defosse is a prominent inventor based in Paris, France, known for his significant contributions to the field of chemistry, particularly in the development of piperidine derivatives. With a total of nine patents to his name, Defosse's work has a considerable impact on pharmaceutical applications.

Latest Patents

Defosse's latest patents include innovative compounds that are piperidine derivatives designed for therapeutic applications. One notable invention involves a compound represented by a formula where R1 is either hydrogen or a linear/branched alkyl group, with various substituents that can include halogens or hydroxyl groups. Another significant patent focuses on a compound that targets 5-HT receptors, providing potential treatments for disorders where these receptors are involved. These piperidine derivatives and their therapeutic applications showcase his dedication to advancing medical science through innovative chemistry.

Career Highlights

Throughout his career, Gerard Defosse has been associated with Synthelabo, a company recognized for its research and development in pharmaceutical innovation. His work in this environment has allowed him to push the boundaries of chemical science and contribute to advancements in therapeutic compounds.

Collaborations

In his journey as an inventor, Defosse has collaborated with esteemed colleagues in the field, including Philippe Michel Manoury and Jean Louis Binet. These partnerships have fostered an environment of creativity and innovation, driving forward the development of new and effective medicinal solutions.

Conclusion

Gerard Defosse stands out as a pioneering inventor in the pharmaceutical sector, with his research on piperidine derivatives reflecting a commitment to improving healthcare through innovative inventions. His contributions continue to shape the landscape of medicinal chemistry, making him a significant figure in his field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…